E. Anders Kolb, MD, a world-renowned pediatric hematologist oncologist and researcher, is president and chief executive officer of Blood Cancer United, formerly The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer. Dr. Kolb leads the mission and operations of this $500 million cancer patient advocacy agency with offices serving patients and families across North America.
Dr. Kolb has devoted his life's work to caring for children with pediatric blood cancer and conducting research to find cures. Before joining the organization, he spent 15 years at Nemours Children's Health, where he built the Blood and Bone Marrow Transplant Program and most recently served as chief of the division of hematology and oncology, director of the Moseley Foundation Institute for Cancer and Blood Disorders, and vice chairman for research in the department of pediatrics at the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Kolb remains as part-time faculty at Nemours with some limited patient care responsibilities.
Prior to his roles at Nemours, Dr. Kolb was a member of the Pediatric Leukemia and Pediatric Stem Cell Transplantation Services at Memorial Sloan-Kettering Cancer Center in New York City; director of the Pediatric Preclinical Chemotherapy Testing Laboratory at the Albert Einstein Cancer Center, Albert Einstein College of Medicine in the Bronx; and director of the Pediatric Leukemia and Lymphoma Service and Pediatric Stem Cell Transplantation at The Children's Hospital at Montefiore, also in the Bronx.
Dr. Kolb has been the principal or co-principal investigator of numerous studies and grants, including clinical trials with the Children's Oncology Group, the Nemours NCI Community Oncology Research Program (NCORP) and the Center of Biomedical Research Excellence (COBRE), which awarded Nemours Children's Health a $10.5 million grant to establish the Delaware Comprehensive Sickle Cell Research Center. From 2013 to 2023, he served as the chair of the Children's Oncology Group Myeloid Disease Committee. From 2018 to 2023, he was co-chair and member of the executive committee of PedAL, a first-of-its-kind global master clinical trial and a key component of the Dare to Dream Project, transforming treatment and care for kids with blood cancer.
Dr. Kolb has authored or co-authored more than 150 articles in peer-reviewed journals and received numerous awards.
Dr. Kolb completed his pediatric residency at St. Christopher's Hospital for Children and fellowship training in hematology/oncology in the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center. He earned his MD from Thomas Jefferson University and his bachelor's degree from the University of Pennsylvania.